ProSpace (190160766)

  https://cordis.europa.eu/project/id/190160766

  Horizon Europe (2021-2027)

  BioProtect Balloon Implant System – Enabling Safe Prostate Radiation Treatment even at extreme dosage

  EIC Accelerator Open 2023 (HORIZON-EIC-2023-ACCELERATOROPEN-01)

  oncology

  2023-10-01 Start Date (YY-MM-DD)

  2025-09-30 End Date (YY-MM-DD)

  € 5,501,632

  Description

Prostate is the 2nd leading cancer in men in the world, with more than 1.4 million men diagnosed every year globally. ~50% of men will be treated with radiation treatment. Radiation is a highly effective treatment; however, it has significant complications, mainly injuring the rectal tissue, approximate to the prostate treatment area. Up to 35% of the patients will experience rectal toxicity side effects such as bleeding, urinary, bowl and erectile dysfunction, damaging severely patient’s quality of life. There is a growing need for a solution that protects the rectum from the radiation field. Our soluton ‘ProSpace’ is a biodegradable medical grade copolymer (70:30 Poly L-Lactide-co-ε-Caprolactone) balloon spacer deployed in the prostate-rectum interspace. It creates a 1.8cm, symmetric distance between the prostate & rectum, allowing physicians to radiate prostate tumours & sparing healthy rectal tissue.

  Complicit Organisations

1 Israeli organisation participates in ProSpace.